Protein from algae shows promise for stopping SARS

May 20, 2009

A protein from algae may have what it takes to stop Severe Acute Respiratory Syndrome (SARS) infections, according to new research. A recent study has found that mice treated with the protein, Griffithsin (GRFT), had a 100 percent survival rate after exposure to the SARS coronavirus (SARS-CoV), as compared to a 30 percent survival for untreated mice.

The research will be presented at the American Thoracic Society's 105th International Conference in San Diego on Wednesday, May 20.

Despite its dramatic entrance into the domain of worldwide public health threats in 2002, little headway has been made therapeutically toward preventing or treating SARS after infection. But GRFT, a lectin protein derived from algae, offers a new possible hope. GRFT is thought to exert its anti-viral effects by altering the shape of the that line the virus' envelope, allowing it to attach to and invade , where it takes over the cells' reproductive machinery to replicate itself. Without that crucial ability, the is unable to cause disease.

"While preliminary, these results are very exciting and indicate a possible therapeutic approach to future SARS or other coronaviral outbreaks," stated Christine Wohlford-Lenane, senior research assistant at the department of pediatrics University of Iowa and the lead author of the study.

Researchers treated experimental with GRFT or a sham treatment and then inoculated them with the SARS virus. They analyzed the antiviral activity of GRFT and the extent to which the virus was able to invade and replicate in the mice at two, four and 10 days after infection. They found that mice who had not been treated with GRFT showed 20 times more plaque-forming units of virus than treated mice. They also noted that the lungs of untreated infected mice showed extensive necrotizing bronchitis and prominent edema, while mice treated with GRFT showed evidence of significantly less severe lung damage. Additionally, mice treated with GRFT did not experience the drastic weight loss of untreated mice, which lost 35 percent of their body mass.

"This indicates that not only did the GRFT stop the virus from replicating, but also prevented secondary outcomes, such as weight loss, that are associated with infection," said Ms. Wohlford-Lenane.

"We are planning future studies to investigate prophylaxis, versus treatment interventions with GRFT, in the SARS mouse model in collaboration with Barry O'Keefe at the National Cancer Institute," she concluded. "In addition, we want to learn whether mice protected from by GRFT develop protective immunity against future infection."

Source: American Thoracic Society (news : web)

Explore further: Ultrasound enhancement provides clarity to damaged tendons, ligaments

add to favorites email to friend print save as pdf

Related Stories

Scientists determine how SARS kills

Jul 14, 2005

Scientists reportedly have developed a therapy to decrease the extraordinarily high death rate associated with the SARS virus.

Study: SARS can infiltrate brain tissue

Sep 15, 2005

Severe acute respiratory syndrome is a disease of the respiratory tract and now scientists say they've found SARS can also infiltrate brain tissue.

Scientists’ studies combat health threats

May 25, 2007

The outbreak of severe acute respiratory syndrome (SARS) in 2002 was a loud wake-up call for researchers studying infectious diseases. SARS infected more than 8,000 people, killed 10 percent of those infected and weakened ...

Recommended for you

A better way to track emerging cell therapies using MRIs

Sep 19, 2014

Cellular therapeutics – using intact cells to treat and cure disease – is a hugely promising new approach in medicine but it is hindered by the inability of doctors and scientists to effectively track the movements, destination ...

User comments : 0